Stockbridge, TN, United States of America

Nicole M Chumbler

This inventor holds 1 USPTO granted patent. Top assignees: The Hospital for Sick Children, Vanderbilt University. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicole M Chumbler. Retrieved from https://idiyas.com/inventor/nicole-m-chumbler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nicole M Chumbler: Innovator in Vaccine Development

Introduction

Nicole M Chumbler is a prominent inventor based in Stockbridge, TN (US). She has made significant contributions to the field of vaccine development, particularly in addressing antibiotic-associated infections in hospitals. Her innovative work focuses on creating vaccines that target toxic proteins to prevent or reduce the severity of infections.

Latest Patents

Nicole M Chumbler holds 1 patent related to modified toxin A and B proteins. These proteins have been engineered to reduce toxicity compared to their native counterparts. The need for such a vaccine is critical, as antibiotic-associated infections are a leading cause of complications in healthcare settings worldwide.

Career Highlights

Throughout her career, Nicole has worked with esteemed institutions such as The Hospital for Sick Children and Vanderbilt University. Her research has been pivotal in advancing the understanding of toxic proteins and their role in infections.

Collaborations

Nicole has collaborated with notable colleagues, including Roman Alexander Melnyk and Zhifen Zhang. Their combined expertise has contributed to the development of innovative solutions in the field of infectious diseases.

Conclusion

Nicole M Chumbler's work exemplifies the importance of innovation in healthcare. Her contributions to vaccine development are vital in the fight against antibiotic-associated infections, showcasing her dedication to improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…